Sort
326,823 grants matching “clinical trial”
ACE2 immunodecoys for long-lasting immunoprophylaxis against sarbecovirus and merbecoviruses that target human ACE2
$2,937,578Samuel Lai · Univ Of North Carolina Chapel Hill · R01 · FY2025 · AI
University of Kentucky Alzheimer's Disease Research Center
$2,937,009Linda J Van Eldik · University Of Kentucky · P30 · FY2022 · AG
Bone Marrow Grafting and Cellular Therapy for Leukemia and Lymphoma
$2,936,016Robert S Negrin · Stanford University · P01 · FY2025 · CA
UofL RBL Operations, Workforce Development and Pandemic Preparedness Research
$2,935,664Kenneth E Palmer · University Of Louisville · UC7 · FY2023 · AI
Pharmacogenomics and Risk of Cardiovascular Disease
$2,935,651Ronald M Krauss · Children'S Hospital & Res Ctr At Oakland · U01 · FY2007 · HL
Children's Oncology Group Phase 1/Pilot Consortium
$2,935,624National Childhood Cancer Foundation · U01 · FY2004 · CA
Baylor College of Medicine Cancer Center
$2,934,758C Kent Osborne · Baylor College Of Medicine · P30 · FY2011 · CA
Baylor College of Medicine Cancer Center
$2,934,758C Kent Osborne · Baylor College Of Medicine · P30 · FY2012 · CA
Natives Engaged in Alzheimer's Research
$2,934,616Lonnie A. Nelson · Washington State University · P01 · FY2023 · AG
Targeting the Chemokine System to Sensitize Tumors to Immunotherapy
$2,934,547Pawel Kalinski · Roswell Park Cancer Institute Corp · P01 · FY2021 · CA
Gene therapy of cancer
$2,934,429Steven Rosenberg · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Makerere Univ.-Johns Hopkins Univ. HIV Clinical Trials Unit-Kampala, Uganda
$2,933,904Mary Glenn Fowler · Johns Hopkins University · UM1 · FY2013 · AI
Durg Development Support for the CTEP
$2,933,647Nora Lee · Technical Resources International, Inc. · N02 · FY2009 · CA
Bone Marrow Transplantation in Human Disease
$2,933,594Richard J Jones · Johns Hopkins University · P01 · FY2010 · CA
Autonomic Pharmacodynamic Pharmacogenomics
$2,933,291University Of California San Diego · U01 · FY2003 · HL
DEFUSE 3: EnDovascular ThErapy Following Imaging EvalUation for ISchemic StrokE 3
$2,933,258Gregory W Albers · Stanford University · U01 · FY2015 · NS
Partnering to treat an Orphan Disease Duchenne Muscular Dystrophy
$2,933,081Kathryn R Wagner · Hugo W. Moser Res Inst Kennedy Krieger · UH2 · FY2013 · TR
Initiative in Stem Cell Biology
$2,932,669Gilbert C. White · Versiti Wisconsin, Inc. · C06 · FY2010 · RR
Discovery and Development of Therapeutic Genes for CHF
$2,932,664H. Kirk Hammond · Veterans Medical Research Fdn/San Diego · P01 · FY2015 · HL
Terry Beirn CPCRA Clinical Trials Unit
$2,932,579Virginia Kan · George Washington University · UM1 · FY2020 · AI
Development of a bioabsorbable, subcutaneous, extended-release buprenorphine implant for opioid use disorder
$2,932,500Steven M Cohen · Drug Delivery Company, Llc, The · UG3 · FY2025 · DA
Prostate Cancer Imaging
$2,931,891Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Systemic Autoimmunity
$2,931,661Mariana Kaplan · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2020 · AR
Molecular Targets Laboratory
$2,931,181James McMahon · Division Of Basic Sciences - Nci · ZIC · FY2016 · CA
Columbia Collaborative HIV/AIDS Clinical Trials Unit
$2,931,000Scott M Hammer · Columbia University Health Sciences · U01 · FY2009 · AI